|
|
Volumn 3, Issue 10, 2002, Pages 582-
|
|
10 years and counting: The hype and hope of cancer biotechnology
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
CETUXIMAB;
DOUBLE STRANDED RNA;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
IMATINIB;
MESSENGER RNA;
PROTEIN KINASE;
RECEPTOR BLOCKING AGENT;
TOXIN ANTIBODY;
APOPTOSIS;
BIOTECHNOLOGY;
CANCER CELL;
CANCER GENETICS;
CANCER LOCALIZATION;
CELL DEATH;
CELL KILLING;
CONTROLLED STUDY;
DRUG TARGETING;
GENE CLUSTER;
GENE INACTIVATION;
GENE MUTATION;
GENE TARGETING;
GENE THERAPY;
NOTE;
ONCOGENE;
PRIORITY JOURNAL;
|
|
EID: 0036796240
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(02)00881-1 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|